Publicação:
Oxacillin Resistance of Staphylococcus aureus Isolated from the University Hospital of Botucatu Medical School in Brazil

dc.contributor.authorMartins, Andre [UNESP]
dc.contributor.authorPereira, Valeria Cataneli [UNESP]
dc.contributor.authorCunha, Maria de Lourdes Ribeiro de Souza da [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:34:29Z
dc.date.available2014-05-20T13:34:29Z
dc.date.issued2010-01-01
dc.description.abstractBackground: Oxacillin is the main drug used for the treatment of Staphylococcus aureus infections. However, resistance of S. aureus to oxacillin has become a major problem over recent decades. The aim of this study was to determine oxacillin resistance in S. aureus isolates obtained from the University Hospital of the Botucatu Medical School, Universidade Estadual Paulista, Brazil. Materials and Methods: A total of 102 isolates collected between 2002 and 2006 were analyzed by detection of the mecA gene, cefoxitin and oxacillin disk diffusion methods, screening test on Mueller-Hinton agar and E-test. Results: Forty-six (45.1%) isolates were mecA positive. The oxacillin disk diffusion method showed 86.9% sensitivity and 91.1% specificity. The screening method and cefoxitin disk diffusion presented a similar sensitivity (91.3%) and the same specificity. The E-test showed 97.8% sensitivity and the same specificity as observed for the other methods. Conclusions: The E-test yielded the best results compared to the other methods. Copyright (C) 2010 S. Karger AG, Baselen
dc.description.affiliationUniv Estadual Paulista, Inst Biociencias, Dept Microbiol & Imunol, BR-18618000 São Paulo, Brazil
dc.description.affiliationUniv Estadual Paulista, Botucatu Med Sch, Dept Trop Dis & Imaging Diag, BR-18618000 São Paulo, Brazil
dc.description.affiliationUnespUniv Estadual Paulista, Inst Biociencias, Dept Microbiol & Imunol, BR-18618000 São Paulo, Brazil
dc.description.affiliationUnespUniv Estadual Paulista, Botucatu Med Sch, Dept Trop Dis & Imaging Diag, BR-18618000 São Paulo, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipIdFAPESP: 06/02765-0
dc.format.extent112-119
dc.identifierhttp://dx.doi.org/10.1159/000313523
dc.identifier.citationChemotherapy. Basel: Karger, v. 56, n. 2, p. 112-119, 2010.
dc.identifier.doi10.1159/000313523
dc.identifier.issn0009-3157
dc.identifier.lattes0115647772315973
dc.identifier.urihttp://hdl.handle.net/11449/11824
dc.identifier.wosWOS:000277570300005
dc.language.isoeng
dc.publisherKarger
dc.relation.ispartofChemotherapy
dc.relation.ispartofjcr2.000
dc.relation.ispartofsjr0,524
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectCefoxitinen
dc.subjectE-testen
dc.subjectmecAen
dc.subjectMRSAen
dc.subjectOxacillinen
dc.subjectStaphylococcus aureusen
dc.titleOxacillin Resistance of Staphylococcus aureus Isolated from the University Hospital of Botucatu Medical School in Brazilen
dc.typeArtigo
dcterms.licensehttp://www.karger.com/Journal/Guidelines/238704#15
dcterms.rightsHolderKarger
dspace.entity.typePublication
unesp.author.lattes0115647772315973
unesp.author.orcid0000-0001-9079-2723[3]
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt
unesp.departmentDoenças Tropicais e Diagnósticos por Imagem - FMBpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 2 de 2
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: